
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
2012 Drug Pipeline : R&D turns to specialty therapies with less generic exposure Cardiometabolic Disease (Part 1) : The pharmacist’s tools for managing dyslipidemia and hypertension Rehabilitating the impaired pharmacist DeKalb and Walgreens discharge med service






